Fox Business - The Power to Prosper
Search Site

Pharmaceuticals

Charles Payne: Invest in these stocks in European market

FBN’s Charles Payne, NewOak Capital President James Frischling, A&G Capital CIO Hilary Kramer, retail analyst Hitha Herzog and Penn Financial Group founder Matt McCall on the opportunities for investors in Europe.

Read More

  1. ING CEO: Europe needs structural reform

    ING CEO Ralph Hamers on the ECB decision, the regulatory environment and the marriage of technology and banking.

  2. NFL’s integrity on the line after Patriots controversy?

    Defense Attorney Arthur Aidala weighs in on the corruption charges against New York Assembly Speaker Sheldon Silver and the controversy surrounding the New England Patriots.

  3. Should the Patriots be penalized before the Super Bowl?

    The Vinnie from Queens panel weighs in on the scandal surrounding the New England Patriots, the payment of NFL cheerleaders and Tiger Woods.

  4. Bill Gates: Health care should be technocratic not bipartisan

    Microsoft Founder Bill Gates discusses the U.S. health-care system and where his foundation is focused on health initiatives.

  5. Study links e-cigs to formaldehyde, cancer risk

    Newark Beth Israel Medical Center Dr. Robert Lahita on the potential health risks of e-cigarettes.

  6. U.S. stocks enjoy ECB-fueled rally

    Claman on Call: FBN’s David Asman with an after-hours web exclusive on the markets, the Patriots scandal and the latest from Davos.

  7. Will the ECB move destabilize the markets?

    Jan Randolph of IHS Global Insight and Head of Multi-Asset Portfolio Management Strategy at QS Investors Wayne Lin discuss how ECB’s bond-buying program will impact the markets.

  8. Will the ECB move destabilize the markets?

    Jan Randolph of IHS Global Insight and Wayne Lin of Legg Mason discuss how ECB’s bond-buying program will impact the markets.

  9. Novartis CEO: New heart drug will be a blockbuster

    Novartis CEO Joseph Jimenez discusses how the Swiss Franc decision affected business, the company’s new heart failure drug , and the ECB’s QE decision.

  10. CNBC threatening to cut guests who speak to FBN?

    FBN’s Liz Claman, Charlie Gasparino and FOX Business Contributor Anthony Scaramucci discuss ‘threat gate’ from the World Economic Forum at Davos.

  11. Startup manufactures battery-powered drones

    Kespry CEO Paul Doersch on building battery-powered drones for the construction industry.

  12. Breaking down quantitative easing

    FOX Business Contributor Bob Rice breaks down exactly what QE is and how it works.

  1. What does Greece election mean to the markets and your money?

    FBN’s Charles Payne, NewOak Capital President James Frischling, A&G Capital CIO Hilary Kramer, small business expert Susan Solovic, retail analyst Hitha Herzog and Penn Financial Group founder Matt McCall on the potential risk of the U.S. becoming the next Greece.

  2. Wall Street’s mixed messages

    FBN’s Charles Payne on the confusing messages from Wall Street.

  3. U.S. stocks hold onto weekly gains

    Claman on Call: FBN’s David Asman with an after-hours web exclusive on the markets and the latest from Davos.

  4. Frenkel talks ECB, economy and terrorism

    JPMorgan Chase International Chairman Jacob Frenkel discusses the ECB stimulus, the Fed, and what he believes is the biggest threat to the global markets.

  5. Will the euro reverse its slide anytime soon?

    UBS AG Chairman Axel Weber on the European economy and the outlook for the euro and Swiss franc.

  6. Mayo Clinic CEO on state of health care

    Mayo Clinic CEO Dr. John Noseworthy discusses his priorities for 2015, patient care and technology in the U.S. and the development and cost of Hepatitis C therapies.

  7. Will the ECB move destabilize the markets?

    Jan Randolph of IHS Global Insight and Head of Multi-Asset Portfolio Management Strategy at QS Investors Wayne Lin discuss how ECB’s bond-buying program will impact the markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Pharmaceuticals on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL